NeuroPace financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

뉴로페이스NASDAQ:NPCE · Nasdaq · Healthcare

$12.70-3.42%

2026-10-02 close

NeuroPace's published financial data is dated 2026-10-04. 2024 revenue was $80M. 2024 operating profit was −$22M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy